Primarily, IL-6 activates signal transducer and activator of transcription 3 (STAT3) signaling thus promotes tumor cell proliferation and enhances cell invasiveness in cancers, which is in line with the constitutive activation of STAT3 in RCC, especially in metastatic disease13,14. This evidence concerns the gene IL6 and cancer.